PMC5657011_01
Shows outstanding clinical events, neutrophil, monocyte, and lymphocyte cells counts over time as well as days of oseltamivir and rimatadine therapy. Chest X-ray at hospital admission, computed tomographic (CT) of the chest obtained during the acute phase with clinical deterioration and CT scan of the chest obtained during the late phase of the Acute Respiratory Distress Syndrome.
IRV-5-167-g001.jpg
PMC5657011_01_IRV-5-167-g001.jpg
f1
F), chills, diaphoresis, headache, malaise, myalgias, and productive cough. Figure 1 shows neutrophils, lymphocytes, and monocytes counts and chest roentgenogram on admission with confluent lower lung air-space opacities. A H1N1 was negative. After 8 days on oseltamivir, he continued with fever; chest CT scan showed bilateral alveolar infiltrates (Figure 1); amphotericin B was started. Organ Failure Assessment (SOFA) scores were 18 and 11 points. A second oseltamivir course was administered for 10 days; 72 hours after discontinuation, the patient developed fever again (39 C/102 F) and breathing difficulty. Oseltamivir and rimantadine were reinitiated and stopped when clinical recovery-associated lymphocyte count reached 500 cells/ml (Figure 1).